Loading data
ULBINasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 191.16 m USD | 164.46 m USD | 158.64 m USD | 131.84 m USD | 98.27 m USD |
| Cost of revenue | 145.14 m USD | 122.14 m USD | 119.44 m USD | 102.44 m USD | 73.63 m USD |
| Gross profit | 46.02 m USD | 42.31 m USD | 39.2 m USD | 29.4 m USD | 24.64 m USD |
| Research and development expense | 10.4 m USD | 8.27 m USD | 7.53 m USD | 7.08 m USD | 6.83 m USD |
| Selling, general and administrative expense | 29.34 m USD | 24.08 m USD | 22.19 m USD | 22.19 m USD | 17.78 m USD |
| Operating profit | -5.9 m USD | 9.97 m USD | 9.48 m USD | 129 k USD | 35 k USD |
| Profit before tax | -8.4 m USD | 8.3 m USD | 9.12 m USD | -446 k USD | -151 k USD |
| Income tax expense | -2.45 m USD | 1.89 m USD | 1.95 m USD | -326 k USD | 79 k USD |
| Net income (reported basis) | -5.9 m USD | 6.31 m USD | 7.2 m USD | -119 k USD | -234 k USD |
| Basic earnings per share | -35 USD/share | 38 USD/share | 0.44 USD/share | 0.05 USD/share | 0.05 USD/share |
| Diluted earnings per share | -35 USD/share | 38 USD/share | 0.44 USD/share | 0.05 USD/share | 0.05 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.